A steroid-inducible promoter for the cornea

British Journal of Ophthalmology

Volumn 93, Issue 9, 2009, Pages 1255-1259

  Parker, D G A ^a   Brereton, H M ^a   Klebe, S ^a   Coster, D J ^a   Williams, K A ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 10; LENTIVIRUS VECTOR; GLUCOCORTICOID;

ARTICLE; CORNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE TRANSFER; GLUCOCORTICOSTEROID RESPONSE ELEMENT; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSGENE; ANIMAL; CORNEA DISEASE; CORNEA TRANSPLANTATION; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; GRAFT REJECTION; IMMUNOLOGY; LENTIVIRINAE; METABOLISM; SHEEP;

ANIMALS; CORNEA; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE THERAPY; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; INTERLEUKIN-10; LENTIVIRUS; RESPONSE ELEMENTS; SHEEP; TRANSGENES;

EID: 70249143628     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.159137     Document Type: Article

References (25)

1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001;79:214-221
2. Williams KA, Esterman AJ, Bartlett C, et al. How effective is corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation 2006;81:896-901. (Pubitemid 44641510)
3. Hudde T, Minassian DC, Larkin DF. Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection. Br J Ophthalmol 1999;83:1348-1352
4. Coster DJ, Williams KA. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 2005;140:1112-1122 (Pubitemid 41821304)
5. Klebe S, Sykes PJ, Coster DJ, et al. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 2001;71:1214-1220 (Pubitemid 32507137)
6. Murthy RC, Mcfarland TJ, Yoken J, et al. Corneal transduction to inhibit angiogenesis and graft failure. Invest Ophthalmol Vis Sci 2003;44:1837-1842 (Pubitemid 36520270)
7. Klebe S, Coster DJ, Sykes PJ, et al. Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium. J Immunol 2005;175:2219-2226 (Pubitemid 41113828)
8. Beutelspacher SC, Pillai R, Watson MP, et al. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 2006;36:690-700.
9. Barcia RN, Dana MR, Kazlauskas A. Corneal graft rejection is accompanied by apoptosis of the endothelium and is prevented by gene therapy with Bcl-xL. Am J Transplant 2007;7:2082-2089 (Pubitemid 47247044)
10. Gong N, Pleyer U, Vogt K, et al. Local overexpression of nerve growth factor in rat corneal transplants improves allograft survival. Invest Ophthalmol Vis Sci 2007;48:1043-1052 (Pubitemid 351261396)
11. Kafri T. Gene delivery by lentivirus vectors an overview. Meth Mol Biol 2004;246:367-390
12. Bennett J. Immune response following intraocular delivery of recombinant viral vectors. Gene Ther 2003;10:977-982 (Pubitemid 36722432)
13. Koldej R, Cmielewski P, Stocker A, et al. Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production. J Gene Med 2005;7:1390-1399 (Pubitemid 41672397)
14. Mader S, White JH. A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells. Proc Natl Acad Sci USA 1993;90:5603-5607 (Pubitemid 23176209)
15. Narumi K, Kojima A, Crystal RG. Adenovirus vector-mediated perforin expression driven by a glucocorticoid-inducible promoter inhibits tumor growth in vivo. Am J Respir Cell Mol Biol 1998;19:936-941 (Pubitemid 128354292)
16. Narumi K, Suzuki M, Song W, et al. Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA. Blood 1998;92:822-833 (Pubitemid 28355465)
17. Parker DG, Kaufmann C, Brereton HM, et al. Lentivirus-mediated gene transfer to the rat, ovine and human cornea. Gene Ther 2007;14:760-767 (Pubitemid 46585657)
18. Leibowitz HM, Kupferman A. Bioavailability and therapeutic effectiveness of topically administered corticosteroids. Trans Am Acad Ophthalmol Otolaryngol 1975;79:OP78-88.
19. Halaby IA, Lyden SP, Davies MG, et al. Glucocorticoid-regulated VEGF expression in ischemic skeletal muscle. Mol Ther 2002;5:300-306 (Pubitemid 34213250)
20. Watson D, Noble MJ, Dutton GN, et al. Penetration of topically applied dexamethasone alcohol into human aqueous humor. Arch Ophthalmol 1998;106:686-687
21. Mcghee CN, Watson DG, Midgley JM, et al. Penetration of synthetic corticosteroids into human aqueous humour. Eye 1990;4:526-530
22. Weijtens O, Schoemaker RC, Romijn FP, et al. Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology 2002;109:1887-1891
23. Latta-Mahieu M, Rolland M, Caillet C, et al. Gene transfer of a chimeric transactivator is immunogenic and results in short-lived transgene expression. Hum Gene Ther 2002;13:1611-1620 (Pubitemid 35034681)
24. Stieger K, Le Meur G, Lasne F, et al. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Mol Ther 2006;13:967-975
25. Beutelspacher SC, Ardjomand N, Tan PH, et al. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. Exp Eye Res 2005;80:787-794 (Pubitemid 40798043)